IndiaInfoline » Markets » NATCOPHARM

Natco Pharma Ltd - Share Price

NATCOPHARM

Open

558.30

Prev. Close

561.30

Turnover (lac.)

3,568

Day's High

560.95

Day's Low

536.95

52 Week's High

848.30

52 Week's Low

536.95

Book Value

201

Face Value

2

Mkt Cap (Cr.)

9,858

P/E

11.8

EPS

45.92

Divi. Yield

1.54

Financials

Switch to
Consolidated
Standalone

Loading ...

News & Updates

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd463.20139.61110,873.27-38.680.432,192.4177.62
Piramal Enterprises Ltd2,649.8569.9948,951.30-67.470.92890.351,086.74
Dr Reddys Laboratories Ltd2,799.1037.1846,513.41399.400.712,718.20725.76
Aurobindo Pharma Ltd789.5533.4546,102.77463.510.483,160.50180.71
Divis Laboratories Ltd1,724.3535.1045,803.95379.490.581,342.92237.46

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

sentifi.com

Indiainfoline Sentifi Top 10 Most Talked About Stocks

Summary & Reports

No Company Summary found

Registered Office

Natco House,Road No 2 Banjara Hills,Hyderabad, Telangana,500033

Tell. : +91-040-23547532
Website : http://www.natcopharma.co.in
Email : investors@natcopharma.co.in

Registrar Office

12-10-167, Bharath Nagar, Hyderbad - 500018 INDIA

Tell. : +91-040-23818475/76/2
Website : www.vccilindia.com
Email : info@vccilindia.com

View

- <

Reco. Price

Mar 06,2019 12:06 PM

Target Price

Target Returns:

0.00%

Result Express

Natco Pharma Ltd's Q2FY19 consolidated net profit rises 115.17% yoy to Rs181.60cr : Misses Estimates

Apr 21, 2019 07:37 AM

The company’s consolidated revenue stood at Rs543.50cr, up 27.37% yoy and 0.91% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Dividend

    Annc. Date

    12 Feb 2019

    Effective. Date

    21 Feb 2019

    Divi. Type

    Interim 2

    Divi.(%)

    175

    Divi. Amt.

    3.5

    Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on ... More

  • Purpose

    Board Meeting

    Exp. Date

    12 Feb 2019

    Annc. Date

    02 Feb 2019

    NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sched... More